ArticleFrontiers in pharmacology2022

Novel Sigma-2 receptor ligand A011 overcomes MDR in adriamycin-resistant human breast cancer cells by modulating ABCB1 and ABCG2 transporter function.

Zhanwei Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.